Ivermectin for COVID-19: real-time meta analysis of 63 studies

Covid AnalysisSep 9, 2021Version 117 — discussion updates (V1 Nov 26, 2020)  [GMK responseElgazzarCarvallo]

Studies Prophylaxis Early treatment Late treatment Patients Authors
All studies 63 86% [75‑92%] 69% [54‑79%] 40% [24‑52%] 26,422 623
Peer-reviewed 45 86% [74‑93%] 70% [52‑81%] 43% [21‑59%] 17,316 490
Randomized Controlled Trials 31 84% [25‑96%] 64% [48‑74%] 30% [2‑50%] 6,561 369
Percentage improvement with ivermectin treatment

Entire Report